Cargando…
IGNITE Status Epilepticus Survey: A Nationwide Interrogation about the Current Management of Status Epilepticus in Germany
We aimed to evaluate the current management of status epilepticus (SE) in intensive care units (ICUs) in Germany, depending on the different hospital levels of care and the ICU specialty. We performed a nationwide web-based anonymized survey, including all German ICUs registered with the German Soci...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910893/ https://www.ncbi.nlm.nih.gov/pubmed/35268262 http://dx.doi.org/10.3390/jcm11051171 |
_version_ | 1784666609140367360 |
---|---|
author | Kowoll, Christina M. Klein, Matthias Salih, Farid Fink, Gereon R. Stetefeld, Henning R. Onur, Oezguer A. Malter, Michael P. |
author_facet | Kowoll, Christina M. Klein, Matthias Salih, Farid Fink, Gereon R. Stetefeld, Henning R. Onur, Oezguer A. Malter, Michael P. |
author_sort | Kowoll, Christina M. |
collection | PubMed |
description | We aimed to evaluate the current management of status epilepticus (SE) in intensive care units (ICUs) in Germany, depending on the different hospital levels of care and the ICU specialty. We performed a nationwide web-based anonymized survey, including all German ICUs registered with the German Society for Neurointensive and Emergency Care (Deutsche Gesellschaft für Neurointensiv- und Notfallmedizin; DGNI). The response rate was 83/232 (36%). Continuous EEG monitoring (cEEG) was available in 86% of ICUs. Regular written cEEG reports were obtained in only 50%. Drug management was homogeneous with a general consensus regarding substance order: benzodiazepines—anticonvulsants—sedatives. Thereunder first choice substances were lorazepam (90%), levetiracetam (91%), and propofol (73%). Data suggest that network structures for super-refractory SE are not permeable, as 75% did not transfer SE patients. Our survey provides “real world data” concerning the current management of SE in Germany. Uniform standards in the implementation of cEEG could help further improve the overall quality. Initial therapy management is standardized. For super-refractory SE, a concentration of highly specialized centers establishing network structures analogous to neurovascular diseases seems desirable to apply rescue therapies with low evidence carefully, ideally collecting data on this rare condition in registries and clinical trials. |
format | Online Article Text |
id | pubmed-8910893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89108932022-03-11 IGNITE Status Epilepticus Survey: A Nationwide Interrogation about the Current Management of Status Epilepticus in Germany Kowoll, Christina M. Klein, Matthias Salih, Farid Fink, Gereon R. Stetefeld, Henning R. Onur, Oezguer A. Malter, Michael P. J Clin Med Article We aimed to evaluate the current management of status epilepticus (SE) in intensive care units (ICUs) in Germany, depending on the different hospital levels of care and the ICU specialty. We performed a nationwide web-based anonymized survey, including all German ICUs registered with the German Society for Neurointensive and Emergency Care (Deutsche Gesellschaft für Neurointensiv- und Notfallmedizin; DGNI). The response rate was 83/232 (36%). Continuous EEG monitoring (cEEG) was available in 86% of ICUs. Regular written cEEG reports were obtained in only 50%. Drug management was homogeneous with a general consensus regarding substance order: benzodiazepines—anticonvulsants—sedatives. Thereunder first choice substances were lorazepam (90%), levetiracetam (91%), and propofol (73%). Data suggest that network structures for super-refractory SE are not permeable, as 75% did not transfer SE patients. Our survey provides “real world data” concerning the current management of SE in Germany. Uniform standards in the implementation of cEEG could help further improve the overall quality. Initial therapy management is standardized. For super-refractory SE, a concentration of highly specialized centers establishing network structures analogous to neurovascular diseases seems desirable to apply rescue therapies with low evidence carefully, ideally collecting data on this rare condition in registries and clinical trials. MDPI 2022-02-22 /pmc/articles/PMC8910893/ /pubmed/35268262 http://dx.doi.org/10.3390/jcm11051171 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kowoll, Christina M. Klein, Matthias Salih, Farid Fink, Gereon R. Stetefeld, Henning R. Onur, Oezguer A. Malter, Michael P. IGNITE Status Epilepticus Survey: A Nationwide Interrogation about the Current Management of Status Epilepticus in Germany |
title | IGNITE Status Epilepticus Survey: A Nationwide Interrogation about the Current Management of Status Epilepticus in Germany |
title_full | IGNITE Status Epilepticus Survey: A Nationwide Interrogation about the Current Management of Status Epilepticus in Germany |
title_fullStr | IGNITE Status Epilepticus Survey: A Nationwide Interrogation about the Current Management of Status Epilepticus in Germany |
title_full_unstemmed | IGNITE Status Epilepticus Survey: A Nationwide Interrogation about the Current Management of Status Epilepticus in Germany |
title_short | IGNITE Status Epilepticus Survey: A Nationwide Interrogation about the Current Management of Status Epilepticus in Germany |
title_sort | ignite status epilepticus survey: a nationwide interrogation about the current management of status epilepticus in germany |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910893/ https://www.ncbi.nlm.nih.gov/pubmed/35268262 http://dx.doi.org/10.3390/jcm11051171 |
work_keys_str_mv | AT kowollchristinam ignitestatusepilepticussurveyanationwideinterrogationaboutthecurrentmanagementofstatusepilepticusingermany AT kleinmatthias ignitestatusepilepticussurveyanationwideinterrogationaboutthecurrentmanagementofstatusepilepticusingermany AT salihfarid ignitestatusepilepticussurveyanationwideinterrogationaboutthecurrentmanagementofstatusepilepticusingermany AT finkgereonr ignitestatusepilepticussurveyanationwideinterrogationaboutthecurrentmanagementofstatusepilepticusingermany AT stetefeldhenningr ignitestatusepilepticussurveyanationwideinterrogationaboutthecurrentmanagementofstatusepilepticusingermany AT onuroezguera ignitestatusepilepticussurveyanationwideinterrogationaboutthecurrentmanagementofstatusepilepticusingermany AT maltermichaelp ignitestatusepilepticussurveyanationwideinterrogationaboutthecurrentmanagementofstatusepilepticusingermany AT ignitestatusepilepticussurveyanationwideinterrogationaboutthecurrentmanagementofstatusepilepticusingermany |